Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Statin Choice Decision Aid Implementation First Phase (SCIP1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02375815
Recruitment Status : Completed
First Posted : March 3, 2015
Last Update Posted : March 24, 2017
Sponsor:
Information provided by (Responsible Party):
Victor Montori, Mayo Clinic

Brief Summary:
This study is designed to answer a key question in the field of implementation science. Specifically, it seeks to determine if a proposed model for the implementation and scale-up of healthcare innovations (the AIDED model) is effective and useful. To fully evaluate the potential of this model, the investigators will conduct a multi-year study comprising 3 phases. This proposal represents the first of these phases.

Condition or disease Intervention/treatment Phase
Cardiovascular Factor Risk Other: Statin Choice Implementation Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 313 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: The Statin Choice Implementation Project: Phase 1
Study Start Date : January 2015
Actual Primary Completion Date : December 2016
Actual Study Completion Date : March 2017

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Statin Choice Implementation Other: Statin Choice Implementation



Primary Outcome Measures :
  1. Effective Implementation of Statin Choice Decision Aid (SCDA), as indicated by the cumulative reach (% usage in appropriate primary care consultations) across all 3 health systems (as measured by EMR-based calculations). [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
Subjects of the Mayo Clinic Care Network

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02375815


Locations
Layout table for location information
United States, Idaho
Kootenai Health
Coeur d'Alene, Idaho, United States, 83814
United States, Minnesota
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
United States, Missouri
Mosaic Life Care
St. Joseph, Missouri, United States, 64506
United States, North Dakota
Altru Health System
Grand Forks, North Dakota, United States, 58206
Sponsors and Collaborators
Mayo Clinic
Investigators
Layout table for investigator information
Principal Investigator: Victor Montori, MD Mayo Clinic

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Victor Montori, MD, Mayo Clinic
ClinicalTrials.gov Identifier: NCT02375815     History of Changes
Other Study ID Numbers: 14-006048
First Posted: March 3, 2015    Key Record Dates
Last Update Posted: March 24, 2017
Last Verified: March 2017
Keywords provided by Victor Montori, Mayo Clinic:
statin
decision aid
Additional relevant MeSH terms:
Layout table for MeSH terms
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Anticholesteremic Agents
Hypolipidemic Agents
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Enzyme Inhibitors
Lipid Regulating Agents